12:00 AM
 | 
Nov 12, 2012
 |  BC Week In Review  |  Company News  |  Deals

NanoCarrier, Orient Europharma deal

The companies amended an October 2008 deal granting Orient rights to NanoCarrier's Nanoplatin. NanoCarrier will grant Orient non-exclusive, worldwide manufacturing...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >